Company: GDSTR
Filing Date: 2025-07-18
Form Type: S-4/A
Source: 0001213900-25-065671
Chunk: 372

Company: Goldenstone Acquisition Ltd.
Filing Date: 2025-07-18
Form: S-4/A
Chunk 372
---
 PER SHARE The following table sets forth the computation of basic and diluted loss per share as follows:

|                                                                            |     | For the      
 Three Months 
 Ended        
 March 31,    
 2025         |            |   |     | For the      
 Three Months 
 Ended        
 March 31,    
 2024         |            |   |
|:---------------------------------------------------------------------------|:----|:-------------|-----------:|:--|:----|:-------------|-----------:|:--|
| Numerator:                                                                 |     |              |            |   |     |              |            |   |
| Net loss                                                                   |     | $            | (1,558,796 | ) |     | $            | (2,096,028 | ) |
| Denominator:                                                               |     |              |            |   |     |              |            |   |
| Weighted average shares used in computing basic and diluted loss per share |     |              | 92,768,284 |   |     |              | 92,267,691 |   |
| Loss per share – basic and diluted                                         |     | $            |      (0.02 | ) |     | $            |      (0.02 | ) |

F-46

INFINTIUM FUEL CELL SYSTEMS, INC.
NOTES TO FINANCIAL STATEMENTS
(Unaudited) NOTE 15 — LOSS PER SHARE (cont.) The calculation of diluted loss per share does not consider the effect of the Company’s warrants and stock options for the three months ended March 31, 2025 and 2024, respectively, as the inclusion of such securities would be anti -dilutive. There were no other anti -dilutivesecurities items. The summary of anti -dilutiveinstruments is as follows:

| Common Stock Issuable                     |     | Stock Options |     |  Warrants |     |      Total |
| For the three months ended March 31, 2025 |     |     7,579,187 |     | 7,444,242 |     | 15,023,429 |
| For the three months ended March 31, 2024 |     |     7,536,687 |     |         — |     |  7,536,687 |

NOTE 16 — COMMITMENTS AND CONTINGENCIES From time to time, the Company is subject to various claims that arise in the ordinary course of business. Management believes that any